Quarterly report pursuant to Section 13 or 15(d)

CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS??? DEFICIT

v3.22.2.2
CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT
9 Months Ended
Sep. 30, 2022
Equity [Abstract]  
CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT

Note 10. CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT

 

In June 2022, the Company completed a 1-for-7 reverse stock split of its Common Stock. All share and per share amounts have been adjusted on a retroactive basis in these condensed consolidated financial statements to reflect the effect of the reverse stock split. The Company will make a cash payment to stockholders for all fractional shares that it would otherwise be required to issue as a result of the stock split. In addition, the stock split resulted in the par value of the Company’s Common Stock increasing to $0.007 per share.

 

Convertible Preferred Stock

 

The Company has authorized a total of 20,000,000 shares of preferred stock, $0.001 par value per share. Prior to the IPO, the Company issued 5,296,044 shares of preferred stock, designated as Series A. In July 2017, the Company completed a private placement of securities in which 1.3 million shares of Series A Preferred Stock were sold, resulting in net proceeds of $1.5 million. As part of the closing, the Company issued 4.0 million shares of Series A Preferred Stock in exchange for $2.6 million of the Company’s convertible notes payable and related accrued interest.

 

In accordance with the Certificate of Designation of the Series A Preferred Stock, all of the shares of Series A Preferred Stock that were issued and outstanding at the time of the IPO Closing were automatically converted into 745,558 fully paid and nonassessable shares of Common Stock at a 1-for-7 conversion rate (as adjusted for the 1-for-7 reverse stock split). The shares of Series A Preferred Stock that were so converted ceased to be part of the Company’s authorized stock and will never again be issued by the Company. As of September 30, 2022, no Preferred Stock is outstanding.

 

Common Stock

 

The Company has authorized a total of 14,285,714 shares of Common Stock, $0.007 par value per share. In November 2021, the Company received stockholder approval to increase the number of authorized shares from 7,142,857 shares to 14,285,714 shares. As of September 30, 2022, the Company has issued 8,369,750 shares of Common Stock.